Omnicare: Old Prescriptions With New Numbers

Whistleblower Justice Network

In the Omnicare invalid-prescription judgment case, the court ordered the long-term-care pharmacy to pay $948,778,444 for billing government health care programs for drugs dispensed without valid prescriptions. The government’s complaint described a system that gave expired prescriptions new numbers and kept the refills moving. If you worked with renewal orders, dispensing software or pharmacy billing, the revealing question is familiar: what actually changed when the computer created that new prescription number?

A former pharmacist-in-charge at Omnicare’s Albuquerque, New Mexico pharmacy brought the whistleblower case, and the government joined it. The case reached beyond that pharmacy to prescriptions for elderly and disabled residents of assisted living and other residential care facilities. Medicare, Medicaid and TRICARE paid the claims at issue.

How Omnicare’s Prescription Rollover Worked

The government’s complaint against Omnicare and CVS alleged that Omnicare kept dispensing after prescriptions expired or exhausted their authorized refills. Instead of obtaining a new prescription, the pharmacy assigned the old one a new number and continued filling it.

The complaint covered conduct from 2010 through 2018. It alleged that prescriptions rolled over in at least 1,766 residential facilities and in at least an additional 1,476 through cycle fill, the automated process for refilling large volumes of medication periodically. Both routes allegedly bypassed the renewal that should have brought the treating physician back into the decision.

The complaint also alleged that some initial dispensings relied on records that were never valid prescriptions from an authorized healthcare provider. An employee checking only the latest fill could miss what had been wrong with the underlying order from the start.

The complaint distinguished Omnicare’s earlier controlled-prescription problems from the non-controlled drugs at issue here. It named antipsychotic drugs, anticonvulsant medications and cardiovascular drugs among the medicines dispensed without valid prescriptions. The government alleged that continued dispensing without current prescriptions exposed residents to dangerous side effects and drug interactions.

The setting explains why renewal mattered. As the complaint described it, assisted living and other residential facilities generally lacked physicians on staff to oversee residents’ medication. Residents relied on their own doctors outside the facility to prescribe, monitor treatment and decide whether a medicine or dose should change. A system that kept old orders moving could bypass that opportunity for review.

Omnicare’s Own Warnings About Expired Prescriptions

The complaint alleged that Omnicare’s own pharmacists, internal auditors and state pharmacy boards had already identified the problem. According to the complaint, an Ohio pharmacist and colleagues repeatedly complained that the pharmacy was not tracking whether prescriptions had authorized refills remaining. An internal audit draft identified missing renewal orders and the absence of an automated control against dispensing beyond twelve months. Management allegedly ignored the pharmacist complaints, and the draft audit reached compliance officers without correction of the problem.

The most revealing passage came from an April 2015 exchange among senior compliance officers:

An issue that I am running into more and more in multiple states concerns the ability of our systems to allow prescriptions to continue to roll after a year to a new prescription number without any documentation or pharmacist intervention.

United States ex rel. Bassan v. Omnicare, Inc., government complaint, paragraph 11, quoting a regional compliance officer

The complaint said the head of Omnicare’s Third Party Audit group responded that a potential solution had been programmed the previous year, but nobody was rolling it out. We see a particularly ugly priority in that account. The software could keep prescriptions moving, and a possible fix already existed. The company allegedly left the fix sitting while pharmacy staff remained under pressure to dispense quickly so claims could be submitted and paid.

The complaint described a separate warning from the New Mexico Board of Pharmacy. Its investigation of the Albuquerque pharmacy found dispensing after refills ran out and drug orders missing quantities, refills or, in some instances, a prescriber’s signature. CVS’s director of regulatory affairs learned of those findings. That places the warning inside the parent company as well as the dispensing pharmacy.

What the Jury Found Against Omnicare and CVS

On April 29, 2025, the jury found Omnicare liable for fraudulently dispensing drugs without valid prescriptions and billing Medicare, Medicaid and TRICARE for over three million false claims. The Justice Department’s verdict announcement separately reported that the jury found CVS Health Corporation liable for causing Omnicare to submit false claims.

The court entered judgment on August 18, 2025. The later court-filed collection agreement recites damages tripled to $406,778,444 and civil penalties of $542 million. CVS shared responsibility for $164.8 million of those penalties, included within the total judgment.

The distinction between the companies matters to someone who saw a policy made above the pharmacy. The complaint alleged that CVS took an active role in overseeing Omnicare’s dispensing practices and systems after acquiring it. The jury’s separate finding addressed CVS’s role in causing the false claims. The U.S. Attorney’s Office for the Southern District of New York pursued the civil case.

The Bankruptcy Agreement Changed the Payment Arrangement

The bankruptcy court approved a compromise on August 12, 2026, setting payment obligations toward the judgment. Its confirmation order records that approval.

Under the approved agreement, CVS must pay $130 million once the agreement becomes effective. It also calls for at least $310 million in distributions from the bankruptcy estates, with CVS responsible for a shortfall under the agreement’s terms. The parent company’s responsibility therefore extended into the payment arrangement as well as the judgment.

What Pharmacy Records Reveal About Invalid Refills

Prescription history, dispensing records and payer claims show different parts of a rollover. An insider’s knowledge connects the order the doctor authorized with the version the pharmacy used and the information sent for payment.

The Order Behind the New Number

The original prescription supplies the authorized quantity, refill limits and expiration information. Renewal orders and pharmacist intervention records show what supported later dispensing. The old and new prescription numbers, together with the rollover or cycle-fill history, show how the system carried the order forward.

We examine that history alongside the employee’s account of the workflow. The Omnicare complaint shows why that comparison matters: an expired order, a computer-generated replacement and a compliance warning about the missing documentation.

The Claim Sent to the Payer

The government alleged that Omnicare transmitted false information making dispensings appear supported by current prescriptions. Its complaint identified claims reaching federal health programs through Medicare Part D plans, Medicaid managed care organizations and pharmacy benefit managers as well as the programs themselves.

A pharmacy benefit manager may process the claim for the Medicare drug plan. The plan sponsor remains responsible to the Centers for Medicare & Medicaid Services when it delegates that work. An insider may therefore see the pharmacy’s source information, the processor’s response or the sponsor’s later report.

That means the dispensing record and the payer’s claim need to be read together. We connect the prescription version, fill date, claim and response history with the remittance and any later correction. A pharmacy systems employee may understand how the prescription number changed. A billing employee may understand what that change told the payer.

The agency describes the sponsor’s Prescription Drug Event data as summary extracts, distinct from individual drug claims. In a rollover case, we compare that summary with the underlying transaction and the order that supposedly authorized it.

The Control That Let the Claim Through

Omnicare’s separate product-code settlements show why the particular system matters. One concerned alleged manual changes to rejected claims. Another concerned an automated verification process that allegedly allowed the manufacturer and National Drug Code on the claim to differ from the product dispensed. The agreement covering that verification process addressed billing accuracy and the ability to trace drugs for recalls.

In the Walgreens uncollected-prescription case, the government alleged that orders moved out of local work queues into a central status without a separate process to resolve them. The settlement agreement described a different disconnect between what pharmacy staff saw and the payment still requiring attention.

Walmart and Sam’s Club settled a separate refill case for $825,000 in 2018. The government alleged that they automatically enrolled beneficiaries and billed for refills despite Minnesota Medical Assistance’s requirement for a new request and warnings from employees. That case concerned the beneficiary’s request for a refill. Omnicare’s rollover allegations concerned the prescriber’s authorization to keep dispensing. Knowing which permission was missing explains why the refill history matters.

These comparisons make the insider’s contribution concrete. A new prescription number, a matched product code or an order cleared from a queue can look complete on a screen. The person who knows what the software actually did can explain the missing step. We connect that explanation to the government’s payment and the decisions that allowed it.

Does a Judgment Determine a Whistleblower Reward?

No. A whistleblower reward is a share of the government’s recovery. The judgment, the bankruptcy payment obligations and the whistleblower’s award are separate amounts.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Talk with our whistleblower experts about the prescription, the warning and the paid claim, and how we can build your strongest case together.

You Know Why the Refills Kept Moving

If you saw orders roll forward without physician renewal, or warnings reach management while billing continued, tell our whistleblower experts what happened inside the pharmacy. We build the case with you and bring in pharmacy fraud whistleblower lawyers who understand dispensing systems, prescription records and government claims. Your knowledge stays central as we work beside you through the case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365